Hydroxychloroquine use and progression or prognosis of COVID-19: a systematic review and meta-analysis.

Naunyn Schmiedebergs Arch Pharmacol · 2021 · PMC7474863 · PMID 32892293

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

distinctly significantno p-value reported

Death (RR = 1.92, 95% CI = 1.26–2.93, P = 0.003) was distinctly significant different in HCQ group compared with ST group in treatment of COVID-19.

also in 48 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.